Compumedics Limited

Equities

CMP

AU000000CMP2

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 06:29:06 07/06/2024 am IST			5-day change	1st Jan Change
0.29 ^AUD	-6.45%		+20.83%	+3.57%

23/05	Compumedics on Track to Reach Record Revenue in 2024, But Warns of Earnings Miss	MT
29/02	Compumedics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Compumedics Limited Provides Earnings Guidance for the Full Year Ending June 30, 2016

July 18, 2016 at 04:51 am IST

Compumedics Limited provided earnings guidance for the full year ending June 30, 2016. For the year, sales are expected to be $37 million (11% growth) while EBITDA is expected to be between $4.5 million to $5.5 million and NPAT of $2.8 million to $3.2 million.

Latest news about Compumedics Limited

Compumedics on Track to Reach Record Revenue in 2024, But Warns of Earnings Miss	23/05	MT
Compumedics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29/02	CI
Compumedics Expects to Hit Record Fiscal H1 Revenue	11/01	MT
Compumedics Secures Two Orders for MEG Systems for AU$9.3 Million	12/12	MT
US FDA Clears Compumedics' Somfit Device for Marketing in the US; Shares Surge 84%	04/12	MT
Compumedics Limited Provides Revenue Guidance for the Financial Year 2024	30/23/30	CI
Compumedics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/23/30	CI
Compumedics Limited's Equity Buyback announced on August 11, 2022, has expired.	10/23/10	CI
Compumedics Limited Provides Revenue Guidance for the Year 2023	06/23/06	CI
Compumedics Limited Re-Affirms Earnings Guidance for the Fiscal Year 2023	04/23/04	CI
Compumedics Limited Announces the Resignation of Paul Jensz as Director	06/23/06	CI
Compumedics Receives US FDA Clearance for EEG Monitoring Device; Shares Up More than 3%	08/23/08	MT
Compumedics Limited Receives 510(K) Clearance from the U.S. Food and Drug Administration for its Okti High-Density EEG Amplication Range	08/23/08	CI
Compumedics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/23/28	CI
Compumedics Expects 7% Growth in Fiscal H1 Revenue	26/23/26	MT
Compumedics Limited Provides Revenue Guidance for the First Half of Fiscal Year 2023	25/23/25	CI
Compumedics Acquires 50% in Austrian Company	27/22/27	MT
Compumedics Advances Sales of Sleep Monitoring Device	20/22/20	MT
Compumedics Limited Provides Earnings Guidance for the Fiscal Year 2023	18/22/18	CI
Compumedics Limited Reports Earnings Results for the Full Year Ended June 30, 2022	18/22/18	CI
Compumedics Limited announces an Equity Buyback for 4,000,000 shares, representing 2.26% of its issued share capital.	11/22/11	CI
Compumedics Limited authorizes a Buyback Plan.	11/22/11	CI
Compumedics Limited Revises Earnings Guidance for the Fiscal Year 2022	14/22/14	CI
Compumedics Limited Provides Earnings Guidance for the Year 2022	27/22/27	CI
Tucson Dunn Retires as Director of Compumedics Limited, Effective 31 March, 2022	31/22/31	CI

Chart Compumedics Limited

Duration

Period

More charts

Company Profile

Compumedics Limited is a medical device company, which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical EEG systems, brain monitoring systems, ultra-sonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It offers Brain Research technologies through the Compumedics Neuroscan brand. Compumedics Neuroscan technologies provide solutions for EEG, ERPs, Source Localization and Functional Neuroimaging. It also provides solutions for sleep applications from high definition 4k full PSG to home sleep testing.

Sector

Advanced Medical Equipment & Technology

Calendar

12/06/2024 - German Society for Epileptology Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
COMPUMEDICS LIMITED	+3.57%	36.58M
THERMO FISHER SCIENTIFIC	+9.48%	221B
DANAHER CORPORATION	+13.72%	198B
INTUITIVE SURGICAL, INC.	+23.79%	148B
BOSTON SCIENTIFIC CORPORATION	+33.39%	112B
SIEMENS HEALTHINEERS AG	+4.75%	66.85B
EDWARDS LIFESCIENCES CORPORATION	+15.59%	52.84B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.16%	50.86B
AGILENT TECHNOLOGIES, INC.	-4.35%	38.75B
GE HEALTHCARE TECHNOLOGIES INC.	-1.27%	35.15B

Other Advanced Medical Equipment & Technology